06/12/2025 | Press release | Distributed by Public on 06/12/2025 14:37
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Effective June 12, 2025, Ernexa Therapeutics Inc. (the "Company"), filed a certificate of amendment to the Company's Restated Certificate of Incorporation, as amended (the "Amended COI") with the Secretary of State of Delaware to effect a reverse stock split of the Company's common stock , at a ratio of 1-for-15.